tiprankstipranks
Trending News
More News >
ExpreS2ion Biotech Holding AB (SE:EXPRS2)
:EXPRS2
Sweden Market

ExpreS2ion Biotech Holding AB (EXPRS2) Financial Statements

Compare
0 Followers

ExpreS2ion Biotech Holding AB Financial Overview

ExpreS2ion Biotech Holding AB's market cap is currently kr51.84M. The company's EPS TTM is kr-18.938; its P/E ratio is ―; ExpreS2ion Biotech Holding AB is scheduled to report earnings on ―, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenuekr 3.01Mkr 7.05Mkr 5.09Mkr 12.23Mkr 5.26M
Gross Profitkr -2.67Mkr 3.40Mkr 5.00Kkr 4.72Mkr -843.00K
Operating Incomekr -67.69Mkr -105.97Mkr -127.61Mkr -48.40Mkr -31.20M
EBITDAkr -42.20Mkr -102.45Mkr -124.49Mkr -46.38Mkr -28.47M
Net Incomekr -36.41Mkr -91.40Mkr -118.61Mkr -43.92Mkr -31.71M
Balance Sheet
Cash & Short-Term Investmentskr 81.54Mkr 57.60Mkr 110.97Mkr 138.88Mkr 106.83M
Total Assetskr 104.53Mkr 78.69Mkr 137.36Mkr 151.96Mkr 118.86M
Total Debtkr 360.00Kkr 1.71Mkr 1.85Mkr 1.92Mkr 2.38M
Net Debtkr -81.18Mkr -55.89Mkr -109.12Mkr -35.19Mkr -104.45M
Total Liabilitieskr 40.11Mkr 13.33Mkr 34.04Mkr 11.61Mkr 24.31M
Stockholders' Equitykr 64.42Mkr 65.36Mkr 103.33Mkr 140.35Mkr 94.55M
Cash Flow
Free Cash Flowkr -34.80Mkr -102.90Mkr -100.00Mkr -46.36Mkr -19.06M
Operating Cash Flowkr -33.93Mkr -100.89Mkr -99.61Mkr -45.65Mkr -18.18M
Investing Cash Flowkr 21.27Mkr -2.02Mkr 105.33Mkr -100.92Mkr -1.08M
Financing Cash Flowkr 34.87Mkr 47.84Mkr 61.46Mkr 74.55Mkr 123.38M
Currency in SEK

ExpreS2ion Biotech Holding AB Earnings and Revenue History

ExpreS2ion Biotech Holding AB Debt to Assets

ExpreS2ion Biotech Holding AB Cash Flow

ExpreS2ion Biotech Holding AB Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis